Phage Treatment for Cystic Fibrosis Lung Infection
Phase 2
63
about 1.2 years
18+
14 sites in AK, AL, AR +7
What this study is about
Researchers are testing whether nebulized phage (BX004) can treat chronic Pseudomonas aeruginosa lung infection in people with cystic fibrosis. The trial will last 455 days and involve comparing BX004 to a placebo, along with their usual CF treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Placebo
- 2.Receive BX004
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Change from Baseline in CFQ-R respiratory domain, Change from Baseline in CFRSD-CRISS, Incidence of treatment-emergent adverse events [safety and tolerability]
Infectious, Respiratory